Two Sigma Investments, LP Legend Biotech Corp Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$63.16 - $76.5 $5.12 Million - $6.2 Million	80,996 Added 69.69%	197,219 $13.2 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $5.38 Million - $8.72 Million	116,223 New	116,223 $8.02 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $6.17 Million - $10.1 Million	-183,862 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $4.49 Million - $6.98 Million	144,890 Added 371.78%	183,862 $6.68 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $1.6 Million - $2.22 Million	38,972 New	38,972 $1.82 Million
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $5 Million - $7.16 Million	-141,689 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $3.66 Million - $5.82 Million	141,689 New	141,689 $5.82 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.5B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.